Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Survey: Population health 'critically important' but minimal progress occurring

Many organizations are thinking about population health and consider it “critically important” to the future of healthcare, but few are in any payer agreements, according to findings from Numerof & Associates.

Thumbnail

The $2.5 billion idea to help New York hospitals in need

An article published earlier this week by Crain’s New York Business examined the two extremes of New York hospitals and a possible way to close that gap. 

Stryker acquiring Sage Products in $2.7 billon deal

Medical technology company Stryker plans to acquire Cary, Ill.–based Sage Products, which manufactures a host of products meant to prevent so-called “never events” in ICUs and hospitals, including hospital-acquired infections.

Partners launches second round of employee innovation grants

Partners HealthCare is launching a second round of Innovation Discovery Grants (IDG) to support the most promising early-stage ideas that can someday improve patient care.

Thumbnail

AMA creates online Zika virus resource center for physicians and patients

In an effort to better educate doctors and their patients about the Zika virus, the American Medical Association (AMA) announced today the creation of the Zika Virus Resource Center.

CHOP opening precision medicine center

The Center for Data Driven Discovery in Biomedicine at The Children's Hospital of Philadelphia (CHOP) aims to advance precision medicine and match the most appropriate treatment to individual patients.

New Proposal to Give Providers and Employers Access to Information to Drive Quality and Patient Care Improvement

MACRA provides expanded opportunity for the use of Medicare and private sector claims data to drive higher quality, lower cost care.

Thumbnail

USPSTF releases updated depression screening guidelines

All adults age 18 and older in the general population—including pregnant and postpartum women—should be screened for depression, according to newly updated guidelines from the United States Preventative Services Task Force (USPSTF).

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.